doxorubicin hydrochloride and daunorubicin hydrochloride

doxorubicin hydrochloride has been researched along with daunorubicin hydrochloride in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, N; Blake, C; Broadhurst, MJ; Bushnell, DJ; Hartmann, HR; Hassall, CH; Keech, E; Stratton, AR; Thomas, GJ1
Acton, EM; Mosher, CW; Tong, GL; Wolgemuth, RL1
Acton, EM; Tong, GL1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

4 other study(ies) available for doxorubicin hydrochloride and daunorubicin hydrochloride

ArticleYear
Synthesis and antitumor activity of 9-[(carbamoyloxy)alkyl]anthracyclines: a novel class of anthracycline derivatives.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:9

    Topics: Animals; Antibiotics, Antineoplastic; Carbamates; Chemical Phenomena; Chemistry; Female; Leukemia L1210; Mice; Stereoisomerism; Structure-Activity Relationship

1990
Intensely potent morpholinyl anthracyclines.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation, Preclinical; Indicators and Reagents; Leukemia L1210; Leukemia P388; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Structure-Activity Relationship

1984
Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin.
    Journal of medicinal chemistry, 1981, Volume: 24, Issue:6

    Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Leukemia P388; Mice

1981
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012